Search for: "Hans Sauer"
Results 1 - 20
of 25
Sorted by Relevance
|
Sort by Date
6 Jun 2012, 9:59 pm
Noonan -- Hans Sauer, Associate General Counsel for Intellectual Property for the Biotechnology Industry Organization (BIO), frequently asks (when discussing patent-eligibility of genes): "What about cucumber genes? [read post]
24 May 2012, 1:00 am
The roundtable was moderated by Hans Sauer of BIO and John M. [read post]
15 Jul 2012, 9:27 pm
Solicitor General, and Hans Sauer of BIO, the brief argues that the patent-eligibility of isolated DNA claims is unchanged by the Supreme Court's decision in Mayo v. [read post]
18 Jun 2010, 9:43 pm
Elizabeth Howard of Orrick Herrington & Sutcliffe LLP will moderate a panel including Sandra Wells, VP and Chief IP Counsel at Affymetrix, and Hans Sauer, Deputy General Counsel for Intellectual Property for the Biotechnology Industry Organization (BIO). [read post]
30 May 2019, 1:40 pm
Hans Sauer; Ms. [read post]
25 Jun 2020, 9:15 am
Birch Bayh; Hans Sauer, the Deputy General Counsel and Vice President for Intellectual Property for the Biotechnology Innovation Organization; Jennifer Gottwald, the Senior Licensing Manager at the Wisconsin Alumni Research Foundation (WARF); and David Korn, the Vice President of Intellectual Property (IP) and Law for the Pharmaceutical Research and Manufacturers of America (PhRMA). [read post]
4 Aug 2009, 9:59 pm
Hans Sauer, the Associate General Counsel for Intellectual Property for the Biotechnology Industry Organization (BIO); Joshua Sarnoff, Professor of the Practice of Law at American University's Washington College of Law; and Shobita Parthasarathy, Co-Director of the Science, Technology and Public Policy Program at the Ford School of Public Policy at the University of Michigan discussed the topic on WAMU, Washington, DC's leading public radio station (see "Gene… [read post]
7 Jan 2011, 8:57 pm
Sarnoff of DePaul University College of Law; Hans Sauer, Ph.D., Associate General Counsel for Intellectual Property for the Biotechnology Industry Organization (BIO); and Jacqueline D. [read post]
10 Feb 2010, 9:59 pm
Hans Sauer, the Associate General Counsel for Intellectual Property for the Biotechnology Industry Organization (BIO); Joshua Sarnoff, Professor of the... [read post]
25 Apr 2011, 9:55 pm
Hans Sauer, Associate General Counsel for Intellectual Property for the Biotechnology Industry Organization... [read post]
18 Jun 2012, 9:31 pm
Sitting on the panel were Annabelle Bennett, a judge sitting on the Federal Court of Australia; Hans Sauer, Associate General Counsel for BIO; and Thomas Triolo, Senior Counsel Merck... [read post]
27 Jun 2008, 4:51 am
Hans Sauer, the... [read post]
9 Jun 2009, 9:59 pm
Hans Sauer, the Associate General Counsel for Intellectual Property for the Biotechnology Industry Organization (BIO); Joshua Sarnoff, Professor of the Practice of Law at American University's... [read post]
18 Apr 2011, 9:55 pm
Hans Sauer, Associate General Counsel for Intellectual Property for the Biotechnology Industry Organization... [read post]
13 May 2007, 9:11 pm
Says Hans Sauer, intellectual-property counsel for the Biotechnology Industry Organization in Washington: "We're not totally thrilled. [read post]
5 Jun 2009, 2:32 pm
Guests included Hans Sauer, Associate General Counsel for Intellectual Property, Biotechnology Industry Organization. [read post]
3 Oct 2008, 5:39 pm
Hans Sauer, Assoc. [read post]
9 Jun 2010, 3:15 am
The Program is described as: Hear the perspectives of leading experts on the need for reform and the current legislative landscape, the pros and cons of bills under consideration, and the future implications for research, licensing, and litigation: The Honorable Paul Michel, Federal Circuit Chief Judge (retired) Congressman Dana Rohrabacher, US House of Representatives Joe Matal, Republican General Counsel, Senate Judiciary Committee Cheryl Miller, Deputy Staff Director for … [read post]
18 Jul 2007, 7:59 pm
Heuser incorrectly writes:The biotech industry appears to have prevailed, at least partly, in a significant early battle.Yesterday the House judiciary committee completed its mark-up of the bill and eliminated the new avenue to challenge patents, according to an analysis by Hans Sauer, an intellectual-property lawyer for the Biotech Industry Organization in Washington.Only the "second window" of post-grant review was removed in the House bill. [read post]
3 Sep 2010, 9:59 am
Speakers include Chris Mammen, Hans Sauer (BIO), Larry Repress, and Fred Hadidi. [read post]
